Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela

Bermúdez, Valmore; Olivar, Luis Carlos; Torres, Wheeler; Navarro, Carla; González, Robys; Diaz, Cristóbal Ignacio Espinoza; Morocho, Alicia; Mindiola, Andres; Chacín, Maricarmen; Arias, Victor; Áñez, Roberto; Salazar, Juan; Riaño-Garzón, Manuel; Díaz-Camargo, Edgar; Bautista, Maria Judith; Rojas, Joselyn

doi:10.12688/f1000research.14571.3

Cited by 10 publications

(7 citation statements)

References 42 publications

(50 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first mentions that some features of MetS stem from the smoking addiction that appeared in 1998 [ 21 ]. Since then, the results of numerous studies have pointed to an increase in the risk of developing MetS in active and second-hand tobacco smokers [ 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. As studies have revealed, nicotine has the ability to inhibit lipogenesis, increase lipolysis as well as the amount of free fatty acids, which leads to the development of insulin resistance and type 2 diabetes mellitus.…”

Section: E-cigarettes and Metabolic Syndromementioning

confidence: 99%

“…For many years, research has been conducted on the influence of smoking on the development of abdominal obesity and higher WHR values [ 24 , 71 , 72 , 73 , 74 , 75 , 76 ]. Differences in the occurrence of abdominal obesity are observed also between the sexes [ 70 ].…”

Section: Abdominal Obesitymentioning

confidence: 99%

“…Moreover, it inhibits aldosterone synthesis in adrenal glands while causing decreased aldosterone excretion [ 93 ]. An overview of sources available on the topic of the influence of traditional cigarettes indicates an increase in values of arterial pressure in smokers [ 24 , 94 ]. In the case of smoking e-cigarettes, the results are ambiguous.…”

Section: Arterial Hypertensionmentioning

confidence: 99%

See 2 more Smart Citations

Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review

Górna

Napierała

Florek

2020

Toxics

View full text Add to dashboard Cite

The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much research has been conducted in the field of e-cigarettes and the risk of metabolic syndrome. Furthermore, taking into account the influence of e-cigarettes vaping on the individual components of metabolic syndrome, i.e, abdominal obesity, insulin resistance, dyslipidemia and elevated arterial blood pressure, the results are also ambiguous. This article is a review and summary of existing reports on the impact of e-cigarettes on the development of metabolic syndrome as well as its individual components. A critical review for English language articles published until 30 June 2020 was made, using a PubMed (including MEDLINE), Cochrane, CINAHL Plus, and Web of Science data. The current research indicated that e-cigarettes use does not affect the development of insulin resistance, but could influence the level of glucose and pre-diabetic state development. The lipid of profile an increase in the TG level was reported, while the influence on the level of concentration of total cholesterol, LDL fraction, and HDL fraction differed. In most cases, e-cigarettes use increased the risk of developing abdominal obesity or higher arterial blood pressure. Further research is required to provide more evidence on this topic.

show abstract

Section: E-cigarettes and Metabolic Syndromementioning

confidence: 99%

Section: Abdominal Obesitymentioning

confidence: 99%

Section: Arterial Hypertensionmentioning

confidence: 99%

See 1 more Smart Citation

Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review

Górna

Napierała

Florek

2020

Toxics

View full text Add to dashboard Cite

show abstract

“…many studies have found a positive association between conventional cigarette smoking and the metabolic syndrome [7][8][9][10][11] , few have examined the effects of e-cigarettes, on MetS and/or its risk factors.…”

mentioning

confidence: 99%

Cigarette type or smoking history: Which has a greater impact on the metabolic syndrome and its components?

Jang

Lee

et al. 2020

Sci Rep

View full text Add to dashboard Cite

Few studies have researched the gender-specific effects of electronic nicotine delivery systems on the metabolic syndrome (MetS) and/or its risk factors (central obesity, raised triglycerides, decreased HDL cholesterol, raised blood pressure, raised fasting plasma glucose). Thus, this study investigated the association between smoking behavior (cigarette type, smoking history) and MetS in a nationally representative sample of Korean men and women. Our study employed data for 5,462 cases of MetS and 12,194 controls from the Korea National Health and Nutritional Examination Survey (KNHANES) for the years 2014 to 2017. Logistic regression analysis was employed to determine the association between type of cigarette (non-smoker, ex-smoker, and current smoker-conventional only, current smoker-conventional and electronic) and the prevalence of metabolic syndrome and its risk factors. Smoking history was clinically quantified by pack-year. No association between cigarette type and MetS was found for men. For women, relative to non-smokers, smokers of conventional cigarettes (OR 1.80, 95% CI 1.02-3.18) and both conventional and electronic cigarettes (OR 4.02, 95% CI 1.48-10.93) had increased odds of MetS. While there was no association between smoking history and MetS for women, for men, conventional smoking history was associated with MetS for individuals with a smoking history of > 25 pack-years (> 25 to ≤ 37.5 OR 1.45, 95% CI 1.04-2.02; > 37.5 to ≤ 50 OR 1.53, 95% CI 1.08-2.18; > 50 OR 1.56, 95% CI 1.07-2.27). Sex differences were found in the association between smoking behavior and MetS. Such findings reveal sociodemographic differences that should be considered for interventions regarding conventional and/or e-cigarette users at risk of metabolic complications. The metabolic syndrome (MetS) and its risk factors (central obesity, raised triglycerides, decreased HDL cholesterol, raised blood pressure, raised fasting plasma glucose) have been vital in helping identify individuals at risk of type 2 diabetes and cardiovascular disease (CVD). Although a catalyst for heart disease, lipid problems, hypertension, dementia, cancer, polycystic ovarian syndrome, and non-alcoholic fatty liver disease 1 , the mechanisms underlying the development of MetS remain obscure. What is certain is that a growing body of literature asserts that various lifestyle factors including smoking, alcohol consumption 2 , diet, and physical activity 3 contribute to its onset. Electronic nicotine delivery systems, also known as e-cigarettes, are battery-powered products that deliver nicotine in the form of an aerosol 4. Currently, the ever use of e-cigarettes is 8.5% in the United States and 6.6% in South Korea 5. Often advertised as a "healthier" alternatives to conventional cigarettes or smoking cessation aids, e-cigarettes purportedly do not involve tobacco combustion and therefore, have reduced toxicant exposure compared to traditional cigarettes 6. However, research on long-term toxicity has been limited and studies attempting to show the effica...

show abstract

“…Smoking-induced oxidative stress and inflammation are treated as key mechanisms for smoking induced disease, which may cause a constant state of elevated inflammation levels in the body 18 , 19 . A number of studies have reported a high correlation between psoriasis and metabolic syndrome 20 , 21 , and smoking is one of the independent risk factors accounting for an increased prevalence both for psoriasis and metabolic syndrome 22 , 23 . However, few studies have been conducted to assess the effect of tobacco smoking on co-morbidities of psoriasis and metabolic syndrome.…”

Section: Introductionmentioning

confidence: 99%

Tobacco smoking was positively associated with metabolic syndrome among patients with psoriasis in Shanghai: A cross-sectional study

Wei¹,

Chen*²,

Yuan³

et al. 2022

Tob. Induc. Dis.

View full text Add to dashboard Cite

INTRODUCTION A number of studies have reported a high correlation between psoriasis and metabolic syndrome (MetS), and tobacco smoking is one independent risk factor accounting for the increased prevalence both for psoriasis and MetS. However, few studies have been conducted to assess the effects of tobacco smoking on co-morbidities of psoriasis and MetS. METHODS We conducted a cross-sectional study with 1014 psoriasis patients recruited from January to May 2021. Patients were recruited with a cluster survey method in Yueyang Hospital (affiliated with Shanghai University of Traditional Chinese Medicine) and Shanghai Skin Diseases Hospital (affiliated with Tongji University). Data were collected by face-to-face questionnaire interviews which included basic information, personal life habits, medical history, and clinical examinations. SPSS 24.0 was used for data analysis and a p<0.05 was considered statistically significant. RESULTS The 1014 psoriasis patients were predominantly males (65.58%), with an average age of 45.98 years (IQR: 34.00–57.00). Of these, 25.74% (261) of psoriasis had MetS and 31.85% (323) were tobacco smokers. Male psoriasis patients had higher tobacco smoking prevalence than female patients. With increasing age and BMI, the prevalence of tobacco smoking among psoriasis patients increased dramatically (p<0.01). Logistic regression indicated that psoriasis patients with tobacco smoking had 1.78 times (95% CI: 1.21–2.60) the probability to have MetS than those without tobacco smoking, even adjusting for potential confounding factors. Moreover, smoking psoriasis patients with MetS consumed more cigarettes per day, with longer smoking duration, but with an older age of smoking initiation. CONCLUSIONS The prevalence of tobacco smoking and MetS among psoriasis patients was high in Shanghai, and tobacco smoking was positively associated with the MetS among psoriasis patients. Clinicians should recommend psoriasis patients to abstain from tobacco smoking and provide tobacco cessation assistance regularly.

show abstract

Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela

Cited by 10 publications

References 42 publications

Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review

Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review

Cigarette type or smoking history: Which has a greater impact on the metabolic syndrome and its components?

Tobacco smoking was positively associated with metabolic syndrome among patients with psoriasis in Shanghai: A cross-sectional study

Contact Info

Product

Resources

About